Skip to content

Diagnostic Errors in Anaphylactic Shock

Context-dependent Diagnostic Accuracy in Anaphylactic Shock

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04825106
Acronym
ANASim
Enrollment
270
Registered
2021-04-01
Start date
2008-01-01
Completion date
2022-12-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnostic Error

Brief summary

Diagnostic accuracy and quality of management in anaphylactic shock is assessed in three conditions: expected, unexpected with no distractor, unexpected with distractor

Detailed description

participants: physicians taking part in voluntary workshops. Participants are allocated to teams of three design: prospective, randomized, single-blind setting: simulated anaphylactic shock intervention: participants are allocated to 3 versions of the scenario: 1) expected, 2) unexpected but no distractor, 3) unexpected with distractor

Interventions

OTHERDiagnostic context

A life-threatening situation occurs in 3 different contexts

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
24 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Physicians taking part in voluntary simulator workshops

Exclusion criteria

* Refusal to participate or to being videorecorded

Design outcomes

Primary

MeasureTime frameDescription
Correct diagnosis of anaphylactic shock15 minutesDiagnosis of anaphylactic shock is explicitly stated by at least one team member within a time frame of 15 minutes after onset

Secondary

MeasureTime frameDescription
Treatment of anaphylactic shock with epinephrine ≥ 0.3mg intravenously5 minutesAnaphylactic shock is correctly treated with epinephrine in an appropriate dose (≥ 0.3mg intravenously) within a time frame of 5 minutes after diagnosis

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026